Dr. Rasha Kelej drives an impactful change in public health landscape in Africa and beyond by providing 2282 scholarships to doctors from 52 countries
Merck Foundation (www.Merck-Foundation.com), the philanthropic arm of Merck KGaA Germany marks 'World Health Day' 2025 in partnership with Africa's First Ladies who are also the Ambassadors of Merck Foundation 'More Than a Mother' Campaign, with a strong reaffirmation of its commitment to improving and revolutionizing healthcare access across Africa, Asia and beyond through their Scholarships and Capacity Building Program.
Senator, Dr. Rasha Kelej, CEO of Merck Foundation shared, 'For over last 13 years, our efforts at Merck Foundation have been to ensure equitable access to healthcare through education, training and awareness initiatives that not only helps transform the patientcare landscape in Africa and Asia but also empower communities and medical professionals.
I am proud to share that together with our Ambassadors, the First Ladies of Africa, we mark World Health Day every single day of the year by building healthcare capacity and transforming patient care landscape. We achieve this by providing more than 2282 scholarships to young doctors providers across 52 countries in Africa, Asia, and beyond, in 44 critical and underserved medical specialties such as Oncology, Diabetes, Preventative Cardiovascular Medicine, Endocrinology, Sexual and Reproductive Medicine, Acute Medicine, Respiratory Medicine, Embryology&Fertility specialty, Gastroenterology, Dermatology, Psychiatry, Emergency and Resuscitation Medicine, Critical Care, Pediatric Emergency Medicine, Neonatal Medicine, Advanced Surgical Practice, Pain Management, General Surgery, Clinical Microbiology and infectious diseases, Internal Medicine, Trauma&Orthopedics, Neurosurgery, Neurology, Cardiology, Stroke Medicine, Care of the Older Person, Family Medicine, Pediatrics and Child Health, Obesity&Weight Management, Women's Health and many more.'
As per a WHO, African region has a ratio of only 1.55 health workers including physicians, nurses and midwives per 1000 people*. This is below the WHO threshold density of 4.45 health workers per 1000 people needed to deliver essential health services and achieve universal health coverage. Therefore, the Merck Foundation scholarships are highly significant, as they provide doctors with specialized training, helping to bridge healthcare gaps and improve patient care in underserved communities.
Senator Dr. Rasha Kelej emphasized, 'Before the launch of Merck Foundation programs in 2012, many countries—including The Gambia, Liberia, Sierra Leone, the Central African Republic, Guinea, Burundi, Niger, Chad, Ethiopia, Namibia, Myanmar, and Bangladesh—had either no or very few specialists in critical fields such as Oncology, Fertility and Reproductive Care, Diabetology, Respiratory Medicine, and Intensive Care.
I am proud to share that many of our alumni have become, or are on their way to becoming, the first specialists in their respective countries. We are building a lasting legacy in Africa.'
Merck Foundation works closely with their Ambassadors, the African First Ladies and local partners such as Ministries of Health, Education, Information&Communication, Gender, Academia, Research Institutions, Media and Art in building healthcare capacity and addressing health, social&economic challenges in developing countries and under-served communities.
Dr. Kelej shared, 'This year's theme, 'Healthy Beginnings, Hopeful Futures,' aligns perfectly with our initiatives to educate young minds on the importance of a healthy lifestyle, as well as diabetes and hypertension awareness. Together with First Ladies of Africa, we have launched two storybooks on these health topics and adapted them into engaging and inspiring animated films'.
Watch Sugar Free Jude Animation Film: https://apo-opa.co/3ZUNRkM
Watch Mark's Pressure Animation Film: https://apo-opa.co/44jfBSV
Merck Foundation also launches awards for the best media, film, fashion designs, and songs on these themes to encourage local artists and young talents to raise awareness about the importance of a healthy lifestyle in their communities, through their everyday work.
Merck Foundation believes that training healthcare providers and building professional healthcare capacity is key to ensuring equitable and quality healthcare across Africa.
'I am happy to announce the Call for Applications for our 2025 Scholarships for young doctors with special focus on female doctors. These include one-year diploma and two-year master degree in 44 critical and underserved medical specialties, which includes both On-Site Fellowship and clinical training programs and Online Diploma programs. The applications are invited through the Office of our Ambassadors and long-term partners, The First Ladies of Africa and Ministry of Health of each country,' shared Senator Dr Rasha Kelej.
To Apply for In campus Scholarships:
To Apply for Online Scholarships, visit:
https://apo-opa.co/4l5CYVF
The selection for each scholarship will be based on request by First Lady Office, Ministry of Health and / or Medical Society with the aim to fill the gaps of public healthcare system in each country.
The selection will be based on eligibility criteria fulfillment of each training Institute and Foundation, scholarship availability and fund availability.
Distributed by APO Group on behalf of Merck Foundation.
Contact:
Mehak Handa
Community Awareness Program Manager
+91 9310087613/ +91 9319606669
mehak.handa@external.merckgroup.com
Join the conversation on our social media platforms below and let your voice be heard:
Facebook: https://apo-opa.co/44cb5FK
X: https://apo-opa.co/4ewccDB
YouTube: https://apo-opa.co/449YO4C
Instagram: https://apo-opa.co/40jgKYf
Threads: https://apo-opa.co/4kYFQ6O
Flickr: https://apo-opa.co/4nszzBQ
Website: www.Merck-Foundation.com
Download Merck Foundation App: https://apo-opa.co/4et0wS4
About Merck Foundation:
The Merck Foundation, established in 2017, is the philanthropic arm of Merck KGaA Germany, aims to improve the health and wellbeing of people and advance their lives through science and technology. Our efforts are primarily focused on improving access to quality&equitable healthcare solutions in underserved communities, building healthcare&scientific research capacity, empowering girls in education and empowering people in STEM (Science, Technology, Engineering, and Mathematics) with a special focus on women and youth. All Merck Foundation press releases are distributed by e-mail at the same time they become available on the Merck Foundation Website. Please visit www.Merck-Foundation.com to read more. Follow the social media of Merck Foundation: Facebook (http://apo-opa.co/44cb5FK), X (http://apo-opa.co/40vRspw), Instagram (http://apo-opa.co/3ThTOVm), YouTube (http://apo-opa.co/449YO4C), Threads (http://apo-opa.co/3GkCY5d) and Flickr (http://apo-opa.co/4nszzBQ).
The Merck Foundation is dedicated to improving social and health outcomes for communities in need. While it collaborates with various partners, including governments to achieve its humanitarian goals, the foundation remains strictly neutral in political matters. It does not engage in or support any political activities, elections, or regimes, focusing solely on its mission to elevate humanity and enhance well-being while maintaining a strict non-political stance in all of its endeavors.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
an hour ago
- Zawya
Opella achieves global B Corp Certification
Egypt – Opella is the first global consumer healthcare company to achieve B Corp Certification, after meeting the rigorous social and environmental standards set by B Lab, the nonprofit behind the certification. This achievement marks a milestone on Opella's journey to deliver responsible self-care for people and planet. This certification follows an intensive four-year transformation effort, during which Opella has redefined its approach to sustainability, innovation, and governance in all countries across its global operations. The company demonstrated strong performance in key areas including climate action, product sustainability, community health, and accountability at leadership level. Julie Van Ongevalle, Opella President and CEO: ' Being B Corp certified globally is a first step on our sustainability journey. We owe it to the incredible work done by our 11,000 employees across the globe, our customers and our consumers. It is a commitment to redefine self-care by proving that business success and sustainability can and must go hand in hand. ' Marissa Saretsky, Chief Sustainability Officer: ' This recognition reflects the ambition that drives us forward. Going through the certifying process has been an amazing catalyst to drive our sustainability transformation, spur innovation, and engage our employees. It sets a global benchmark, and we are committed to leading from the front by turning high standards into everyday action. This is just the beginning. ' Feirouz Ellouze, Opella Africa,Middle East, Turkiye (AMET) General Manager: " B Corp certification marks the beginning of our journey to deepen our commitment to environmental stewardship. At Opella, we believe that our mission to bring health into the hands of our consumers is inseparable from our responsibility to care for the planet. Sustainability isn't a side initiative—it's a core part of who we are and what we do. We can't deliver health without honoring the planet—because true well-being begins with a thriving world." Key achievements include a 64% reduction in Scope 1 and 2 greenhouse gas emissions since 2019 and sourcing over 93% of Opella's electricity from renewable sources. As of 2024, 97% of Opella's paper-based packaging comes from certified or recycled materials. Additionally, since 2022, Opella's partnership with local NGOs on community programs has directly benefited over 1 million people, and in 2024 alone, its educational campaigns on health awareness and responsible use of medicine reached over 129 million individuals. Opella joins a community of committed companies and encourages more self-care players to join the journey toward greater responsibility and impact. Looking ahead, Opella views B Corp certification as a dynamic framework for continued progress. Its commitment to recertify regularly ensures the company remains focused on advancing innovative, inclusive, and measurable solutions for a healthy society and planet. About B Lab: B Lab is a nonprofit transforming the global economy to benefit all people, communities, and the planet. A leader in economic systems change, our global network creates standards, policies, tools, and programs for business, and we certify companies, known as B Corps, who are leading the way. To date, our community includes 950,000 workers in over 9,600 B Corps across 102 countries and 161 industries. About Opella. Opella is the self-care challenger with third-largest portfolio in the Over-The-Counter (OTC) & Vitamins, Minerals & Supplements (VMS) market globally. Our mission is to bring health in people's hands by making self-care as simple as it should be. For half a billion consumers worldwide – and counting. At the core of this mission are our brands worldwide, our 11,000-strong global team, our 13 best-in-class manufacturing sites and 4 specialized science and innovation development centers. Headquartered in France, Opella is the proud maker of many brands worldwide, including Telfast, Doliprane, Bronchicum, Enterogermina, Maalox, Nasacort, Maxilase, Bisolvon and Buscopan, B Corp certified, we are active players in the journey towards healthier people and planet.
Zawya
2 hours ago
- Zawya
New Urgent Care Clinic at Aster Hospital, Al Qusais to ensure fast access to expert care for non-life-threatening emergencies
Dubai, UAE – Aster Hospital, Al Qusais, recognized in Newsweek's 'World's Best Smart Hospitals 2025' List among 350 hospitals globally and ranked No. 14 on Newsweek's World's Best Hospitals in the UAE list, has announced the launch of its new Urgent Care Clinic, a dedicated facility designed to deliver fast, GP-led care for patients with urgent but non-life-threatening conditions. Led by experienced General Practitioners across General Medicine, Pediatrics and Gynecology, the clinic operates daily from 10:00 PM to 6:00 AM and allows patients to walk in without an appointment, addressing a growing need for convenient and timely access to care, particularly outside of regular hospital hours. The initiative aligns with the UAE'S ongoing efforts to enhance patient care by offering timely alternatives for non-emergency cases, especially during peak hours. It highlights the importance of diversified care pathways to help reduce waiting times and ensure emergency resources are prioritized for patients in critical need. Recognizing this gap, Aster's new Urgent Care Clinic provides an alternative path for patients requiring immediate attention for conditions such as minor injuries, cold and flu symptoms, stomach upsets, pregnancy-related urgencies, and pediatric concerns. Patients are encouraged to visit the Urgent Care Clinic for conditions that are urgent but not life-threatening such as fever, diarrhea, pregnancy discomfort, or minor injuries rather than going to the ER, which should be reserved for emergencies like chest pain, severe bleeding, or loss of consciousness. Conveniently located near Reception A, Ground Floor of Aster Hospital, Al Qusais, the facility is fully equipped with rapid diagnostics and staffed by experienced General Practitioners in General Medicine, Pediatrics, and Gynecology. With quick diagnostics and short wait times, the clinic ensures that patients are treated timely and efficiently, without the stress of navigating a crowded emergency room. Dr. Sherbaz Bichu, CEO of Aster Hospitals & Clinics – UAE, Bahrain, and Oman, emphasized that the clinic was developed with the community's needs at heart. 'The introduction of an urgent care clinic within the Aster hospital Qusais, is a strategic move to alleviate the pressure on the emergency room (ER) by redirecting non-emergent cases. This approach not only enhances patient care but also improves the overall efficiency of hospital services. Patients with minor injuries, illnesses, or those requiring immediate but non-life-threatening care can access the urgent care clinic, ensuring the ER is reserved for critical emergencies. This initiative will result in shorter wait times, especially for pediatric and obstetrics /gynecology patients, ultimately leading to improved patient satisfaction.' Moreover, the urgent care clinic can serve as a bridge for patients who may need follow-up care or referrals, further enhancing the continuity of care. It represents a proactive step in modern healthcare management, focusing on patient needs and optimizing hospital operations. Adding to this, Dr. Ramanathan Venkiteswaran, Consultant Paediatrician & Group Medical Director, Aster Hospitals and Clinics UAE, said, 'We often see that families and patients have to wait for the needed care, which often aggravates the challenge. Our General Practitioners and supporting medical teams will ensure that patients receive timely, condition-appropriate treatment, bridging the gap between outpatient visits and emergency care. This clinic enhances the efficiency of our healthcare system by directing non-emergency cases to the right place.' This initiative also complements broader national healthcare efforts to improve access and efficiency. According to recent data from the UAE National Guard Command, 22,903 emergency cases were responded to by National Ambulance in the first quarter of 2025 (January–March). Notably, over 40% of these cases (9,372) received on-site medical attention, without needing hospital transfer. [1] This highlights a significant portion of emergency cases that could be better managed in dedicated urgent care settings, reinforcing the pressing need for community-based alternatives like the Urgent Care Clinic at Aster Hospital, Al Qusais. The clinic is covered under standard insurance policies, further encouraging accessibility for patients. While there is no telehealth support currently offered, virtual care integration via platforms like myAster is being planned for future implementation. The launch aligns with Aster DM Healthcare's long-term strategy to decongest emergency rooms and expand access to healthcare within communities. While there is no immediate roadmap for replication, the performance and impact of this unit will inform future expansions across the UAE. For more information or to visit the Urgent Care Clinic at Aster Hospital, Al Qusais, patients are welcome to walk in between 10 PM and 6 AM. For inquiries, please contact the hospital directly or visit About Aster DM Healthcare FZC in GCC Founded in 1987 by Dr. Azad Moopen, Aster DM Healthcare is a leading integrated healthcare provider, with a strong presence across 5 countries in the GCC and Jordan. Aster is committed to the vision of providing accessible and high-quality healthcare, from primary to quaternary services, with its promise of 'We will treat you well'. The organisation's robust integrated healthcare model includes 15 hospitals, 122 clinics, and 313 pharmacies in GCC serving all segments of the society through three differentiated brands: Aster, Medcare and Access. Aster consistently adapts to meet the evolving needs of patients, ensuring access to quality healthcare through both physical and digital channels which is exemplified with the launch of the region's first healthcare super app, myAster. For more information about us, please contact: Lavanya Mandal Head of PR and Internal Communications Aster DM Healthcare Email: Udhayan Sasidharan Nair Manager - PR & Communications Aster DM Healthcare Email:
Arabian Business
3 hours ago
- Arabian Business
The economics of prevention: How maternal RSV immunisation can strengthen public health systems
While respiratory syncytial virus (RSV) typically causes mild symptoms in adults, the virus can be life-threatening for infants. The seasonal virus is the most common cause of lower respiratory tract infections (LRTIs) in infants and young children worldwide, accounting for an estimated 33 million LRTIs each year. This global trend is reflected in the Middle East and North Africa region, where RSV is the leading cause of acute respiratory tract infections in young children. In addition to causing LRTIs, RSV leads to over three million hospital admissions and nearly 60,000 deaths globally in children under five each year. Maternal vaccinations not only help protect one of the most vulnerable population groups but also support national healthcare systems and economies by reducing both direct and indirect costs. The economic impact of infant RSV The health impact of RSV in infants results in a heavy burden on national healthcare systems. In Dubai alone, a recent 10-year retrospective cohort study showed that nearly half of patients with RSV were aged under 2 years; of these patients, 22 per cent were hospitalised with an average hospital stay of four days and a hospitalisation cost of US$9.8 million. Meanwhile, in Saudi Arabia, researchers recently projected that if nothing changes, RSV will drive roughly 86,000 infant hospitalisations and US$817.9 million in associated medical costs over the next five years. However, the economic impact of RSV in infants extends beyond the hospital, as parents often miss work to care for their sick infants, leading to a loss in economic productivity. The science behind maternal vaccines Maternal vaccines leverage the natural infant protection mechanism that occurs during pregnancy, providing a boost to the levels of antibodies to shield infants during the first months of life before they are eligible to receive vaccines directly. This transfer of antibodies from mother to fetus is so efficient that by the time a baby is born at full term, the concentration of antibodies in the baby's blood is often even higher than in the mother's. Maternal vaccines have come a long way since the 1800s, when it was first observed that infants born to women vaccinated against smallpox during pregnancy were protected in early life. Today, pharmaceutical leaders are constantly investing in research and development (R&D) efforts related to maternal vaccines while prioritising the safety of both mother and child. Pfizer has leveraged years of vaccines expertise and new scientific discoveries to bring forward a maternal RSV vaccine with the potential to harness a mother's natural ability to provide protection to growing babies through the transfer of antibodies in the womb. This maternal immunisation is currently helping to protect infants in their vulnerable first months of life from disease caused by this highly contagious virus. The potential impact of maternal RSV vaccines By preventing RSV in infants, maternal vaccinations have the potential to reduce the economic impact of the disease. According to recent research, increasing the uptake of the maternal vaccine in KSA to 90 per cent will have a budget impact of US$741.8 million, compared to US$1,689.7 million with a 25 per cent uptake. In addition to direct medical costs, costs related to parent absenteeism will also be reduced, resulting in a more productive and efficient economy. Reducing the impact of RSV in infants will also free up hospital beds, making way for other urgent infant healthcare needs, resulting in a stronger healthcare infrastructure. Beyond the economic impact of maternal RSV vaccines, and of much higher importance, preventing RSV in infants has the potential to safeguard infant lives and can contribute to national government efforts to reduce infant mortality rates.
